Gene Query: TMEM183A

Dataset Description Geneva Score
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 53.33
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 53.33
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 48.05
hnRNP C is a key regulator of protein synthesis in mitosis 33.59
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 28.93
Heterogeneous nuclear ribonucleoprotein C1/C2 links transcriptional and splicing actions of 1,25-dihydroxyvitamin D 27.33
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 25.79
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 22.96
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 22.41
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 18.98
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 18.98
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 18.47
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 18.2
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 18.12
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 17.93
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 17.62
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 16.85
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 16.44
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 16.33
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 15.83
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 15.74
Differetially expressed genes after hTR overexpression in U2OS cells 15.66
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 15.54
The regulartory role of ZCCHC24 in splicing machinery 15.32
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 14.93
NRDE2 negatively regulates nuclear exosome functions 14.77
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 14.57
Active translatome profiling with RiboLace in MCF7 cells 14.28
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 14.27
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 14.05
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 13.77
RNA-Seq with and without RNase treatment in PCa cell lines 13.5
Ribosome profiling and RNA sequencing of MCF10A-ER-Src and fibroblast cell transformation 13.24
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 13.22
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 13.13
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 12.69
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 12.62
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 12.27
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.23
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 12.18
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 11.63
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 11.63
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 11.4
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 11.4
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 11.32
MYC dependent mRNA translation shapes gene expression and cell biology 11.25
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 11.2
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 10.84
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 10.79
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 10.66
Co-regulation of splicing by Rbfox1 and hnRNP M 10.66
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 10.64
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 10.56
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 10.56
Transcriptome of U251 cells overexpression complement component 7 10.52
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 10.51
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 10.41
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 10.28
RNA transcriptome analysis during HSV-1 infection 10.27
Gene expression changes caused by KRAS in MCF-10A 10.17
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 10.09
Genome wide expression change by RNF168 knocking down in NEC cells 10.09
Global analysis of enhancer targets: Mosaic-seq 10.07
Mitochondrial dsRNA triggers antiviral signalling in humans 10.0
3’ Uridylation Expands miRNA Target Repertoire 9.86
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 9.85
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 9.82
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 9.73
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.69
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 9.69
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 9.59
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 9.51
Ribosomal footprinting of CN34-Parental and CN34-LM1a 9.49
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 9.48
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 9.32
Identification of Nrf2 regulated genes by RNA sequencing 9.32
Nrf2 regulated genes in A549 cells 9.32
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 9.24
An RNA-centric dissection of host complexes controlling flavivirus infection 9.14
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 9.14
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 9.0
Global response to chemotherapy-induced apoptosis 8.94
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 8.93
scRNASeq analysis of cycling cardiomyocytes 8.88
RNA-Seq analysis of breast cancer cells after shikonin treatment 8.81
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 8.81
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 8.79
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 8.77
Tracking distinct RNA populations using efficient and reversible covalent chemistry 8.77
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 8.76
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 8.76
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 8.76
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 8.75
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 8.73
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 8.73
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 8.61
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 8.56
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 8.54
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.54
Transcriptome analysis upon C6orf203 silencing 8.51
CROP-Seq in Primary Human T Cells 8.43
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 8.42
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 8.38
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 8.38
Control of prostate tumour growth by the long non-coding RNA GHSROS 8.37
Lysine benzoylation is a novel histone mark [RNA-seq] 8.36
Lysine benzoylation is a novel histone mark 8.36
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 8.32
Cleavage Factor Im as a key regulator of 3’ UTR length 8.23
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 8.22
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 8.19
Integrating single-cell transcriptomic data across different conditions, technologies, and species 8.08
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 8.06
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 8.05
Gene expression profile in breast cancer cell lines using RNA sequencing 8.01
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 7.97
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 7.97
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 7.89
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 7.88
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 7.82
Global expression profiles in cardiac progenitor cells generated by ISX-9 7.74
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 7.74
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 7.72
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 7.72
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 7.72
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 7.72
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 7.65
Sensing self and nonself circular RNAs 7.63
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 7.57
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 7.57
Solid phase chemistry to covalently and reversibly capture thiolated RNA 7.55
Pharmacologic inhibition of STAT5 in AML 7.54
Genome-wide discovery of human splicing branchpoints [RNAse] 7.44
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 7.43
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 7.37
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.33
T47D RNA-seq and ChrRNA-seq data 7.33
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 7.32
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 7.32
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 7.29
Transcriptomic profiling of O-GlcNAcylated mRNA-protein complexes by using OG-CLAP in HeLa cells. 7.29
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 7.29
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 7.28
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 7.25
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 7.25
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 7.25
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 7.24
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 7.23
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 7.23
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 7.22
RNA m5C Methylation in breast cancer using MeRIP-Seq 7.19
Transcriptomic analyssis following EHMT1/2 inhibition 7.19
LncRNA expression profiling of ischemic stroke patients 7.15
MYCL and EP400 are required for Max and MCPyV mediated gene activation 7.15
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 7.08
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 6.97
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 6.95
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 6.95
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 6.91
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 6.85
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 6.84
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 6.84
Differentially expressed vascular development genes for iPSC-ECs from CDI 6.84
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 6.82
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 6.77
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.74
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 6.72
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 6.72
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 6.71
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 6.7
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 6.69
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.69
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.69
U1 snRNP telescripting regulates size-function stratified human genome 6.63
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.56
miRNAs affected by antagomiR-17 treatment 6.52
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 6.49
Noncoding regions are the main source of targetable tumor-specific antigens 6.48
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 6.46
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 6.46
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 6.44
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 6.44
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 6.4
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 6.4
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 6.35
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 6.35
RNA Sequencing Reveals Immunosuppressive Role of Anthrax Lethal Toxin in Human Lung Epithelial and Monocytic Cells 6.29
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 6.28
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 6.25
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 6.24
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 6.23
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 6.18
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.15
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 6.11
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 6.11
Differential gene expression profiles in imatinib-resistant cell lines 6.11
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 6.07
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 6.07
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.06
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 6.06
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.05
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 6.04
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 6.02
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 5.99
Neonatal and adult human testis defined at the single-cell level 5.96
RNA-seq analysis of RALD iPSCs after in vitro differentiation 5.95
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 5.92
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 5.92
Knockdown of ADNP in HCT116 colon cancer cells 5.92
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 5.92
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 5.91
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 5.81
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 5.77
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 5.77
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 5.74
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 5.74
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 5.7
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.7
Gene expression changes associated with resistance to tagraxofusp (SL-401) 5.59
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 5.58
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 5.58
Transcriptome landscape of HeLa response upon triamcinolone acetonide 5.49
hTERT promotes cell adhesion and migration independent of telomerase activity 5.47
nELAVL HITS-CLIP in Alzheimer's Disease patients 5.46
Controlling for gene expression changes in transcription factor protein networks. 5.46
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 5.46
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 5.4
Transcriptomes of human monocytes after ex vivo exposure to uric acid 5.38
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 5.37
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 5.37
SLIGRL-induced gene expression changes in NHEK cells 5.35
METTL3 and WTAP 5.34
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 5.29
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 5.26
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 5.25
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 5.25
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.24
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 5.23
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 5.21
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 5.21
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 5.17
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 5.17
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.13
Improved genome-wide mapping of uncapped and cleaved transcripts in eukaryotes—GMUCT 2.0 5.08
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 5.08
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 5.06
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.06
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.06
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 5.04
High-throughput sequencing of pluripotent cells 5.04
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 4.99
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 4.95
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 4.9
Exploring ILF2 regulatory genes by next-generation sequencing 4.86
Chromatin-informed inference of transcriptional programs in gynecologic cancers 4.82
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 4.82
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 4.82
LIN28A Over-expression RNAseq 4.81
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.78
Identification of a LIF-responsive replication-competent human β cell 4.77
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 4.69
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.67
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.67
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 4.65
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 4.65
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 4.65
Novel Targeting of Transcription and Metabolism in Glioblastoma 4.64
Total RNA-seq in ALL-SIL upon TLX1 knockdown 4.63
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 4.61
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.6
The comparison of high-throughput single-cell RNA-seq methods 4.6
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.55
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 4.5
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 4.5
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 4.5
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 4.49
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 4.49
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.49
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 4.48
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.44
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 4.44
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 4.43
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 4.43
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 4.39
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 4.36
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 4.35
Trans-differentiation of human adult peripheral blood T cells into neurons 4.35
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.34
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 4.33
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 4.33
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 4.25
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 4.23
FMRP-associated MOV10 facilitates and antagonizes miRNA-mediated regulation 4.22
RNA seq with AML (NB4) cells upon FTO inhibition 4.2
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.2
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 4.17
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 4.17
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 4.15
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 4.12
Mechanistic Model-Guided Study of Embryonic Morphogenesis 4.1
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 4.09
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 3.98
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.93
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.91
RNA sequencing of HepG2 cells treated with estradiol or estrogen receptor agonist 3.7
RNAseq in Alzheimer's Disease patients 3.67
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 3.64
Systematic discovery of endogenous human ribonucleoprotein complexes 3.6
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.58
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.58
RNA Sequencing of three pairs of gastric cancer 3.57
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.56
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 3.55
Long non-coding RNA profiling of human lymphoid progenitors reveals transcriptional divergence of B cell and T cell lineages 3.54
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 3.54
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.5
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 3.48
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 3.47
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 3.47
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 3.45
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 3.44
RNA sequencing of primary human platelets and in vitro cell lines 3.43
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 3.43
Transcription elongation regulates genome 3D structure 3.37
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.32
Transcriptome of invasive mucinous adnocarcinoma of the lung and adjacent normal lung tissues from 6 patients based on RNA-seq method 3.29
Tpl-2 and MEK small molecule inhibitors 3.29
Tpl-2 small molecule project 3.29
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.24
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.22
The transcriptome and chromatin accessbility landscape of mammalian germline 3.18
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.16
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.05
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.05
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.03
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 3.02
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 3.0
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.0
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.99
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.97
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 2.94
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 2.9
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 2.86
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.85
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.85
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 2.84
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 2.8
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 2.79
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 2.68
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 2.62
Retinoic acid suppresses MYB in adenoid cystic carcinoma 2.62
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.57
Measure transcript integrity using RNA-seq data 2.55
Effect of ILF3 on translation during homeostasis and the antiviral response 2.54
Generation and persistence of human tissue-resident memory T cells in lung transplantation 2.52
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.46
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 2.42
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 2.41
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.36
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 2.36
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.33
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.25
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.25
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.19
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 2.19
Iron response of HepG2 cells 2.17
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.17
Transposon-based construction of strand-specific RNA-seq libraries 2.14
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 2.13
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 2.13
Induced DNA demethylation, genome instability and transcription 2.12
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 2.12
Biological effect of chronic mistranslation in mammalian cells 2.12
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 2.1
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 2.09
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 2.02
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 2.02
MicroRNA-125a-5p overexpression in human macrophages 1.95
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.92
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.92
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 1.89
Transcriptome of human ILC2s; primary vs IL-1b-primed 1.86
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 1.84
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.79
p63 controls the enhancer landscape during keratinocyte differentiation 1.79
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.75
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.73
The bromodomain protein BRD4 regulates splicing during heat shock 1.68
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.66
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.65
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.6
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 1.59
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 1.59
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  1.59
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 1.58
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 1.58
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.58
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 1.58
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.56
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.53
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 1.52
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 1.51
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 1.46
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 1.43
Comparative Analysis of Cas9 Activators Across Multiple Species 1.43
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.39
EGR1-controlled transcriptome of T HESCs 1.38
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 1.38
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.35
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.35
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.33
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.33
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.33
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.3
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.3
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.26
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.25
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.24
Dual RNA-seq – High-resolution comparative Dual RNA-seq time-course 1.19
Dual RNA-seq of diverse human, mouse and pig cell-types infected with various Salmonella strains 1.19
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.19
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.19
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.19
Hepatic transcriptome of pediatric hepatoblastoma. 1.17
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 1.16
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.15
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 1.1
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 1.08
High-resolution comparative analysis of great ape genomes 1.07
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 1.02
MARS Seq data from human cortical organoids 1.01
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.0
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.98
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 0.97
SF3B1 Degron knockdown RNA-seq 0.97
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.93
Transcriptome analysis of peripheral blood monocytes 0.9
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 0.89
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 0.89
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 0.87
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 0.86
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.86
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.86
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.85
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 0.84
Regulation of highly expressed hCINAP on translatome 0.82
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 0.8
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 0.79
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.76
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.74
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.72
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.71
Global transcriptome analysis of WT versus HEB-/- hESCs 0.69
Heterozygous mutations in SMARCA2 lead to impaired neurogenesis due to global retargeting of SMARCA4 0.69
Differential YAP expression in glioma cells induces cell competition and promotes tumorigenesis 0.67
RNA-seq data 0.65
The DPYSL2 gene connects mTOR and schizophrenia 0.65
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.62
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.62
Ribosome profiling upon inhibition of eIF4A 0.61
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.61
RNA editing in nascent RNA affects pre-mRNA splicing 0.6
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.58
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.58
p53 activity results in DNA replication fork processivity 0.58
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.57
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.53
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.52
Gene expression profile in breast cancer cells 0.52
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 0.52
Profiles of Long Noncoding RNAs in Human Naive and Memory T Cells 0.52
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.52
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 0.45
RNA sequencing with KSHV infection and enrichment for circular RNAs 0.42
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.39
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.38
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.37
Aging-associated patterns in the expression of human endogenous retroviruses 0.36
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.34
Myc activation coordinates gene transcription and protein translation responses 0.34
Genome-wide transcriptome analysis of organotypic rafts derived from human papillomavirus type 16 infected primary keratinocytes [3D raft] 0.29
Bi-allelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney 0.28
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.28
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.27
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 0.26
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.26
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.24
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 0.22
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 0.21
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.2
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 0.18
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.17
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 0.17
Genome-wide analysis of the Integrator complex (HTS) 0.1
Genome-wide analysis of the Integrator complex 0.1
Function and hormonal regulation of GATA3 in human first trimester placentation 0.08
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.06
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.03
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.02
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation